• 首頁
  • 網站地圖
  • Webmail
  • Intranet
ScinoPharm Taiwan
  • 關於神隆
    • About ScinoPharm
    • The ScinoPharm Advantages
    • Milestones
    • Award & Recognitions
    • Organization Chart
    • Management Team
    • 最新消息
    • 企業永續發展
    • Company Video
    • Contact Us
    • 檔案下載
  • 產品與服務
    • 產品與服務
    • Product List
      • Summary of Certificate of Suitability
    • Manufacturing
      • Facilities
      • Capacities
      • Equipment
    • Injectable Manufacturing Services
      • ScinoPharm Injectable Plant
    • Small Molecule Drugs
    • CRAM Services
      • Chemistry Skill
      • Analytical and Regulatory Services
      • Chemical Process Development
      • Clinical Drug Substances
      • Consulting Services
    • Peptide
  • 品質與規範
    • Quality and Compliance
    • Quality Compliance and Management
    • Intellectual Property Compliance
    • Responsible Care/EHS/Waste Treatment/AEO Authorization
  • 投資人關係
    • 投資人關係
    • Shareholders Services
      • Stock Quotes & Dividend History
      • Announcements
      • Shareholders’ Meeting
      • 活動訊息
    • Financials
      • Annual Report
      • Financial Report
      • 月營收資訊
    • Corporate Governance
      • Board of Directors
      • Committees
      • Internal Audit
      • Major Internal Policies
    • 企業永續發展
    • Contact
  • 菁英招募
    • Careers
    • Choose ScinoPharm
    • Learning and Development
    • Salary and Benefits
    • Join us
  • 全球網站
  • 員工專區

2007/4/26
  • About ScinoPharm
  • The ScinoPharm Advantages
  • Milestones
  • Award & Recognitions
  • Organization Chart
  • Management Team
  • Press Releases
  • Careers
    • Choose ScinoPharm
    • Learning and Development
    • Salary and Benefits
    • Join us
  • 企業社會責任
  • Company Video
  • Contact Us

關於我們

Founded in 1997, with initial on-site operations beginning in November 1999, ScinoPharm offers a wide array of process R&D services and API manufacturing capabilities designed to satisfy customers' exact requirements and facilitate their rapid market introductions. ScinoPharm specializes in process R&D and the production of CGMP Active Pharmaceutical Ingredients (APIs).

最新消息

  • ScinoPharm Taiwan Maintains Stable Operations, Actively Expands into Formulation Development and CDMO Business

    2025/3/15

  • ScinoPharm Partners with Handa Pharmaceuticals to Advance 505(b)(2) Drug Development

    2024/12/19

  • ScinoPharm Taiwan Achieves Zero-Deficiency Record in ANVISA Inspection, Expanding Its Presence in Emerging Markets

    2024/11/21

ScinoPharm Taiwan

No.1, Nan-Ke 8th Rd., Shan-Hua, Tainan 741014, Taiwan

info@scinopharm.com

886-6-505-2888

Copyright ©2025 ScinoPharm Taiwan all rights reserved